Gradalis Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Dallas, TX USA
Total Funding:$40M
Industry:Biotech
Founded:2003
Lead Investor(s):N/A
Press
Claim your profile

State Ranking

Estimated Revenue & Financials

  • Gradalis's estimated annual revenue is currently $6.7M per year.
  • Gradalis's estimated revenue per employee is $155,000
  • Gradalis's total funding is $40M.

Employee Data

  • Gradalis has 43 Employees.
  • Gradalis grew their employee count by 43% last year.
  • Gradalis currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Food Safety Net...
$49.8M3215%N/A
Bellicum Pharma...
$1.1M148-11%N/A
G-CON Manufactu...
$9.5M6133%N/A
BioNews Service...
$9.3M6011%N/A
Santa Cruz Biot...
$27M174N/AN/A
Luminex Corpora...
$169.6M109410%N/A
Asuragen
N/A167N/AN/A
Family Tree DNA
$6.2M4018%N/A
XBiotech USA
$11.6M7512%N/A
VGXI, Inc. - cG...
N/A49N/AN/A
Missing a competitor? Contribute!?
Submit

We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil®, our proprietary immunotherapy platform in multiple advanced cancer indications.

keywords:N/A

43

Number of Employees

$6.7M

Revenue (est)

1

Current Jobs

43%

Employee Growth %

$40M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Meghan ManleySenior Project ManagerEmail Available
David ShanahanChief Executive Officer & Chairman of the BoardEmail Available
Luisa ManningVP of Medical & Scientific AffairsEmail Available
Ruth ChavezExecutive Assistant to President
John NemunaitisChief Medical OfficerEmail Available
Gladice WallravenVice President, Clinical and Regulatory OperationsEmail Available
David ShanahanChairman & CEOEmail Available
Walter ChenVice President - Finance & Corporate Development (and Board Secretary)Email Available
Kay Easterwood-SanchezData Manager

Gradalis News

09/09/2019 - Global RNA Drugs Market 2019-2025 Calimmune, Dicerna ...

Global RNA Drugs Market 2019-2025 is a comprehensive report which provides a detailed overview of the major driver, opportunities, ...

03/04/2019 - Gradalis Announces Medical Leadership Team Promotion

DALLAS, March 04, 2019 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational ...

09/06/2019 - RNAi Technology Market Research Report Analysis And ...

Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics, among others, hold the substantial market ...